Chapter 74

Transcatheter Interventions for Aortic Valve Insufficiency in Patients with Left Ventricular Assist Devices

Gabriel A. Hernandez

Gabriel A. Hernandez

Cardiovascular Division, Department of Medicine, University of Mississippi Medical Center, Jackson, MI, USA

Search for more papers by this author
JoAnn Lindenfeld

JoAnn Lindenfeld

Cardiovascular Division, Department of Medicine, University of Mississippi Medical Center, Jackson, MI, USA

Search for more papers by this author
Sandip Zalawadiya

Sandip Zalawadiya

Cardiovascular Division, Department of Medicine, University of Mississippi Medical Center, Jackson, MI, USA

Search for more papers by this author
First published: 20 January 2023

Summary

Aortic insufficiency (AI) is a common adverse event associated with continuous-flow left ventricular assist device (LVAD) support and can lead to serious outcomes, including mortality. Continuous ventricular unloading and prolonged asymmetric aortic valve (AV) closure result in leaflet fusion and myxoid degeneration, which may lead to pan-cyclic AI. Transcatheter aortic valve replacement (TAVR) has emerged as an off-label tool to overcome this maladaptive effect.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.